Member Content

Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)Member Content

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML

มีนาคม 21, 2025
Member Content

Recorded VDO

อ่านต่อไป

A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement

มกราคม 10, 2025
Member Content

Recorded VDO

อ่านต่อไป

Basic Cancer Immunology for Clinicians

ธันวาคม 26, 2024
Member Content

Recorded VDO

อ่านต่อไป

Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy

พฤศจิกายน 27, 2024
Member Content

Recorded VDO

อ่านต่อไป

Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused anti-tumor activity with reduced potential for toxicity in vivo

พฤศจิกายน 7, 2024
Member Content

Recorded VDO

อ่านต่อไป

CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma

ตุลาคม 23, 2024
Member Content

Recorded VDO

อ่านต่อไป

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

ตุลาคม 23, 2024
Member Content

Recorded VDO

อ่านต่อไป

RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma

ตุลาคม 2, 2024
Member Content

Recorded VDO

อ่านต่อไป

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

กรกฎาคม 3, 2024
Member Content

Recorded VDO

อ่านต่อไป

Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level

มิถุนายน 14, 2024
Member Content

Effective adaptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level https://www.ttci-th.org/wp-content/uploads/2024/06/SiCORE-CIT-Journal-Club-14-Jun-2024.mp4

อ่านต่อไป

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML

A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement

Basic Cancer Immunology for Clinicians

Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy

Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused anti-tumor activity with reduced potential for toxicity in vivo

CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma

FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy

Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level

“เปิดบ้านวิจัย…จากห้องแล็บสู่ชีวิตจริง”

Assessment of NCDs indicators in PM2.5-exposure individuals to develop screening innovation system “Telehealth” for sustainable community